Treatment with blocking mAb against the integrins LFA-1 and α4β1 displaces the MZ B cells from the splenic marginal zone28, and has been used to study the role of these cells in host defence following infection with spirochete bacteria of the genus Borrelia29,30 and the intracellular parasite Leishmania donovani32. Here, ITGAL is linked to infection.